Memorial Sloan Kettering Cancer Center

“The promise of AI to transform biology is real, and it’s important — but it needs to be done right.

MSK computational biologist Dr. Christina Leslie discusses how AI could help design better therapies and decode why tumors resist treatment. Learn more: bit.ly/4AbPMkF

Shrinking a tumor before surgery helped protect a young patient’s voice.

MSK experts took an unconventional approach, using larotrectinib to make a less extensive operation possible. Read about her treatment: bit.ly/4yQT77s

Catch up on the cancer research MSK presented at #ESMO26. 🔬

Our roundup covers a pancreatic cancer vaccine, targeted therapy for advanced GIST, and new treatment approaches for ovarian cancer, lung cancer, and sarcoma.

Learn more: bit.ly/3UR6d6V

As members of the @CAIAorg, MSK is helping accelerate development and deployment of AI models to improve cancer care

"Rather than developing separate tools for every clinical question, we are training foundational models across institutions," says Dr. @SohrabShah, Chief of Computational Oncology in the Department of Epidemiology and Biostatistics at MSK.

"Our goal is to develop models that learn from patients full clinical trajectories with multimodal data and at national scales. This will ultimately inform clinical recommendations for new patients, leading to improved personalized treatment and care."

Learn more ⬇️

There's a lot of buzz around mRNA #cancervaccines, but how do they actually work?

These vaccines help train your body’s immune system to recognize the unique genetic signature of cancer cells. Once activated, the immune system can:

🔹 Target and attack cancer cells while helping spare healthy cells
🔹 Work alongside other cancer treatments
🔹 Create a lasting immune response that may help prevent cancer from returning or spreading

📽️ Hear more from Dr. Vinod Balachandran (@TheVinodLab), Director of the Olayan Center for Cancer Vaccines at MSK, about what patients should know about experimental mRNA cancer vaccines.